Grafiche Favillini (Arcadia SGR) takes over 100% of Idea Grafica: all the firms

Milano, 13 July 2020Grafiche Favillini and Idea Grafica, companies belonging to the Favillini Group, active in the market of secondary packaging for the pharmaceutical and nutraceutical sectors, announced a new strategic partnership to set up a company for the Italian market in the development and manufacturing of casing and warning labels for the main Italian pharma companies.

Grafiche Favillini, possessed for the majority by Arcadia SGR, as for 40% by brothers Eugenio and Alberto Favillini and for the minority by industrial investors, took over 100% of Idea Grafica from the Pettinari family, with Laura Pettinari reinvesting in the Favillini Group.

Grafiche Favillini has been assisted in the transaction by law firm Nctm as legal advisor, with Matteo Trapani, Laura Elena Cinquini and Martina Villa; by Russo De Rosa Associati for the structuring of the transaction and legal and fiscal due diligence, with a team made up by Leo De Rosa, Gianmarco Di Stasio, Alberto Greco, Alessandro Manico, Alessandro Manias, Andrea Massaccesi, Francesco Belletti and Lucia Uguccioni.

Legal advisor of Idea Grafica was law firm Pavia e Ansaldo with Alberto Bianco and Nicoletta Botta.

Credit Agricole Italia and Ubi Banca were involved in the transaction as for financing, supported by Simmons & Simmons with Davide D’Affronto and Maria Ilaria Griffo.

Idea Grafica, located in the Milan district, was founded in 2003 and, under the direction of Franco Pettinari and his daughters Laura and Alessandra, benefitted of a turnover significant increase, affirming itself as one of the main suppliers of casing and warning labels for the pharmaceutical and nutraceutical sectors at a national level. In 2019 the company generated revenues for Euros 12 million, with an Ebitda higher than 15%.

The Group that is going to be stablished, with over 25 million euros’ turnover and approximately 130 employees, three factories (one of which entirely dedicated to the production of warning labels), near the main districts of Italian pharma business in Lombardy, Tuscany and Lazio, will have the dimensions and structure needed to supply and follow the growth of the main Italian companies in the pharmaceutical and nutraceutical sectors.